Generate Biomedicines, Inc. GENB
13.06 USD +0.49 (+3.90%)
At closeNov 6, 2026, 4:00 PM EST
13.06 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
12.47 Day range 13.17
11.21 52-week range 20.38
- YTD
- +3.24%
- 1 year
- +3.24%
News
benzinga.com Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market Generate Biomedicines & Zealand Pharma team up to develop AI-engineered protein therapies for obesity & metabolic diseases.
benzinga.com Generate Biomedicines To Receive $30M Upfront, Up To $1.2B In Milestones And Tiered Royalties Under Zealand Pharma Collaboration Generate Biomedicines Inc. (NASDAQ:GENB) ("Generate") today announced a multi-target strategic collaboration with Zealand Pharma A/S (NASDAQ:ZEAL), a biotechnology company transforming the future of…
benzinga.com HC Wainwright & Co. Reiterates Buy on Generate Biomedicines, Maintains $30 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Generate Biomedicines (NASDAQ:GENB) with a Buy and maintains $30 price target.
benzinga.com Roswell Park And Generate Biomedicines Announce First Patient Dosed In First-In-Human Clinical Trial Evaluating GB-5267, Investigational, Autologous IL-18 Armored CAR T-Cell Therapy Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trialsFirst patient treated in new clinical…- benzinga.com HC Wainwright & Co. Reiterates Buy on Generate Biomedicines, Maintains $30 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Generate Biomedicines (NASDAQ:GENB) with a Buy and maintains $30 price target.
benzinga.com Ulta Beauty To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday Wall Street analysts updated ratings for top names. Workday target raised, Ulta Beauty & Genasys targets lowered. See how others view these stocks.- benzinga.com HC Wainwright & Co. Maintains Buy on Generate Biomedicines, Raises Price Target to $30 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Generate Biomedicines (NASDAQ:GENB) with a Buy and raises the price target from $25 to $30.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Biohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular session. The market value of their outstanding shares is at $2.1 billion. SCYNEXIS (NASDAQ:SCYX) stock…- benzinga.com Generate Biomedicines Q2 EPS $(0.52) Beats $(0.57) Estimate, Sales $6.314M Miss $6.625M Estimate Generate Biomedicines (NASDAQ:GENB) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 73.2 percent increase over losses of…
benzinga.com Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session US stock futures lower as Dow falls 100 points. Nike shares down 4% after Q4 results. Shutterstock, Optimum Communications, Cronos, and others also drop.
benzinga.com Why Constellation Brands Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket Constellation Brands (NYSE: STZ) rose in pre-market trading after reporting strong Q1 earnings and raising its FY27 guidance. Other gainers include DXF, EHGO, JEM, TC, VMAR, LGPS, BTOG, LUNR, and BE.…
benzinga.com This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top Wall Street analysts changed outlook on top names. Check our analyst ratings page for upgrades, downgrades, initiations. See opinions on CRDO.
benzinga.com This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. KBH, SOLV, SDHC, GENB coverage initiated.